2009
P9. Age as a Key Determinant of Mortality, Impairment and Disability Following Traumatic Spinal Cord Injury: Analysis of the NASCIS-3 Database
Furlan J, Bracken M, Fehlings M. P9. Age as a Key Determinant of Mortality, Impairment and Disability Following Traumatic Spinal Cord Injury: Analysis of the NASCIS-3 Database. The Spine Journal 2009, 9: 118s. DOI: 10.1016/j.spinee.2009.08.267.Peer-Reviewed Original Research
2008
Article 6: Functional Recovery in the Geriatric Population Following Acute Traumatic Spinal Cord Injury: Analysis of the Third National Acute Spinal Cord Injury Study Database
Furlan J, Bracken M, Fehlings M. Article 6: Functional Recovery in the Geriatric Population Following Acute Traumatic Spinal Cord Injury: Analysis of the Third National Acute Spinal Cord Injury Study Database. Archives Of Physical Medicine And Rehabilitation 2008, 89: e2. DOI: 10.1016/j.apmr.2008.08.014.Peer-Reviewed Original Research202. Assessment of Age as Key Determinant of Mortality and Neurological Outcome after Acute Traumatic Spinal Cord Injury: Analysis of the NASCIS-2 Database
Furlan J, Bracken M, Fehlings M. 202. Assessment of Age as Key Determinant of Mortality and Neurological Outcome after Acute Traumatic Spinal Cord Injury: Analysis of the NASCIS-2 Database. The Spine Journal 2008, 8: 101s. DOI: 10.1016/j.spinee.2008.06.241.Peer-Reviewed Original Research
2007
The Impact of Age at The Time of Injury on the Mortality and Neurological Outcome After Acute Traumatic Spinal Cord Injury: Examination of the NASCIS-2 Database
Furlan J, Bracken M, Fehlings M. The Impact of Age at The Time of Injury on the Mortality and Neurological Outcome After Acute Traumatic Spinal Cord Injury: Examination of the NASCIS-2 Database. Spine: Affiliated Society Meeting Abstracts 2007, &NA;: 19-20. DOI: 10.1097/01.brs.0000317716.47139.aa.Peer-Reviewed Original Research
2002
Steroids for acute spinal cord injury
Bracken M. Steroids for acute spinal cord injury. Cochrane Database Of Systematic Reviews 2002, cd001046. PMID: 12137616, DOI: 10.1002/14651858.cd001046.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsAcute spinal cord injurySpinal cord injuryHours of injuryCord injuryMethylprednisolone therapySteroid treatmentPharmacological therapyRandomized trialsRecent trialsNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudyHigh-dose methylprednisolone steroid therapySpinal Cord Injury StudyMotor neurologic functionOnly pharmacological therapyNorth American trialsLumbar disc diseaseStart of treatmentMethylprednisolone sodium succinateCochrane Injuries GroupYears post injurySteroid therapyMaintenance infusionDose regimenInjury group
2001
Methylprednisolone and Acute Spinal Cord Injury
Bracken M. Methylprednisolone and Acute Spinal Cord Injury. Spine 2001, 26: s47-s54. PMID: 11805609, DOI: 10.1097/00007632-200112151-00010.Peer-Reviewed Original ResearchConceptsAcute spinal cord injurySpinal cord injuryCord injuryMethodologic qualitySystematic reviewImproved functional recoveryHigh methodologic qualityNeurologic recoveryClinical recoveryPharmacologic therapyFunctional recoveryRandomized trialsInjury trialsCochrane LibraryEffective therapySurgical trialsEarly treatmentFurther trialsTherapeutic interventionsInjuryMeSH headingsMethylprednisoloneScore improvementPatientsEvidence base
2000
Clinical Measurement, Statistical Analysis, and Risk-Benefit: Controversies from Trials of Spinal Injury
Bracken M, Aldrich E, Herr D, Hitchon P, Holford T, Marshall L, Nockels R, Pascale V, Shepard M, Sonntag V, Winn H, Young W. Clinical Measurement, Statistical Analysis, and Risk-Benefit: Controversies from Trials of Spinal Injury. Journal Of Trauma And Acute Care Surgery 2000, 48: 558-561. PMID: 10744306, DOI: 10.1097/00005373-200003000-00036.Commentaries, Editorials and LettersConceptsNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudyAcute spinal cord injurySpinal Cord Injury StudyClinical measurementsHigh-dose methylprednisoloneSecondary neuronal damageSpinal cord injuryRisk benefitNeuronal damageFunctional recoverySafety profileCord injuryPharmacologic agentsSpinal injuryInjury studiesInnovative therapiesTrialsStatistical analysisInjuryMulticenterMethylprednisoloneSeries of trialsTherapyPrevention
1999
Magnetic resonance imaging and neurological recovery in acute spinal cord injury: observations from the National Acute Spinal Cord Injury Study 3
Shepard M, Bracken M. Magnetic resonance imaging and neurological recovery in acute spinal cord injury: observations from the National Acute Spinal Cord Injury Study 3. Spinal Cord 1999, 37: 833-837. PMID: 10602525, DOI: 10.1038/sj.sc.3100927.Peer-Reviewed Original ResearchConceptsMagnetic resonance imagingAcute spinal cord injurySpinal cord injuryCord injuryMotor functionResonance imagingSpinal cord injury centerBlind clinical trialInitial neurological examinationInitial clinical examinationLight touch sensationComplete cord injurySpinal cord surgeryMultiple logistic regressionNational InstitutePresence of edemaComplete injuryNeurological recoveryRandomized patientsStudy drugCord edemaNeurological statusCord surgeryNeurological examinationNeurological assessment
1998
Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial.
Bracken M, Shepard M, Holford T, Leo-Summers L, Aldrich E, Fazl M, Fehlings M, Herr D, Hitchon P, Marshall L, Nockels R, Pascale V, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial. Journal Of Neurosurgery 1998, 89: 699-706. PMID: 9817404, DOI: 10.3171/jns.1998.89.5.0699.Peer-Reviewed Original ResearchConceptsAcute spinal cord injurySpinal cord injuryHours of injuryCord injuryFunctional recoveryRandomized double-blind clinical trialMortality rate 1 yearDouble-blind clinical trialMotor function recoveryMP regimenMotor recoveryMP therapyTherapy 3Neurological gradeMorbidity rateSphincter controlFunction recoveryMethylprednisolone regimenClinical trialsMedical factorsTreatment groupsPatientsRegimenInjurySelf-CareMethylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up
Bracken M, Shepard M, Holford T, Leo-Summers L, Aldrich E, Fazl M, Fehlings M, Herr D, Hitchon P, Marshall L, Nockels R, Pascale V, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Neurosurgical FOCUS 1998, 5: e1. DOI: 10.3171/foc.1998.5.3.1.Peer-Reviewed Original ResearchAcute spinal cord injuryHours of injurySpinal cord injuryFunctional recoveryCord injuryMortality rate 1 yearDouble-blind clinical trialMotor function recoveryMP regimenMethods PatientsMotor recoveryMP therapyTherapy 3Neurological gradeMorbidity rateSphincter controlFunction recoveryMethylprednisolone regimenClinical trialsMedical factorsTreatment groupsPatientsRegimenInjurySelf-CareAdministration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury
BRACKEN M, SHEPARD M, HOLFORD T, LEO-SUMMERS L, ALDRICH E, FAZL M, FEHLINGS M, HERR D, HITCHON P, MARSHALL L, NOCKELS R, PASCALE V, PEROT P, PIEPMEIER J, SONNTAG V, WAGNER F, WILBERGER J, WINN H, YOUNG W. Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury. Survey Of Anesthesiology 1998, 42: 197. DOI: 10.1097/00132586-199808000-00011.Peer-Reviewed Original Research
1997
Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997, 277: 1597-604. PMID: 9168289, DOI: 10.1001/jama.277.20.1597.Peer-Reviewed Original ResearchConceptsAcute spinal cord injurySpinal cord injuryNational Acute Spinal Cord Injury StudyFunctional Independence MeasureHours of injuryCord injuryTirilazad groupRegimen groupMethylprednisolone infusionAcute Spinal Cord Injury StudySpinal Cord Injury StudySpinal cord injury centerEfficacy of methylprednisoloneImproved motor recoveryMotor recovery rateAdministration of methylprednisoloneMotor function changesSteroid therapyMethylprednisolone groupSevere sepsisTirilazad mesylateMotor recoveryControlled TrialsInitial presentationIntravenous bolusAdministration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial
Bracken M, Shepard M, Holford T, Leo-Summers L, Aldrich E, Fazl M, Fehlings M, Herr D, Hitchon P, Marshall L, Nockels R, Pascale V, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA 1997, 277: 1597-1604. DOI: 10.1001/jama.1997.03540440031029.Peer-Reviewed Original ResearchAcute spinal cord injurySpinal cord injuryNational Acute Spinal Cord Injury StudyFunctional Independence MeasureHours of injuryCord injuryTirilazad groupRegimen groupTirilazad mesylateMethylprednisolone infusionAcute Spinal Cord Injury StudySpinal Cord Injury StudySpinal cord injury centerEfficacy of methylprednisoloneImproved motor recoveryMotor recovery rateAdministration of methylprednisoloneMotor function changesSteroid therapyMethylprednisolone groupSevere sepsisMotor recoveryControlled TrialsInitial presentationIntravenous bolus
1994
The Effectiveness of Surgery on the Treatment of Acute Spinal Cord Injury and Its Relation to Pharmacological Treatment
Duh M, Shepard M, Wilberger J, Bracken M. The Effectiveness of Surgery on the Treatment of Acute Spinal Cord Injury and Its Relation to Pharmacological Treatment. Neurosurgery 1994, 35: 240???249. DOI: 10.1097/00006123-199408000-00009.Peer-Reviewed Original ResearchThe effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment.
Duh M, Shepard M, Wilberger J, Bracken M. The effectiveness of surgery on the treatment of acute spinal cord injury and its relation to pharmacological treatment. Neurosurgery 1994, 35: 240-8; discussion 248-9. PMID: 7969831, DOI: 10.1227/00006123-199408000-00009.Peer-Reviewed Original ResearchConceptsSpinal cord injuryCord injuryPharmacological treatmentSecond National Acute Spinal Cord Injury StudyNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudyAcute spinal cord injurySpinal Cord Injury StudySevere spinal cord injuryTraumatic spinal cord injuryValue of surgeryRole of surgeryEffectiveness of surgerySpinal cord surgeryNASCIS IINeurological improvementEarly surgeryIncomplete injuriesNeurological recoveryNeurological scoreLate surgeryCord surgeryRandomized studySurgical treatmentMotor scoresThe effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2
Shepard M, Bracken M. The effect of methylprednisolone, naloxone, and spinal cord trauma on four liver enzymes: observations from NASCIS 2. Spinal Cord 1994, 32: 236-245. PMID: 8022633, DOI: 10.1038/sc.1994.43.Peer-Reviewed Original ResearchConceptsSpinal cord injuryCord injuryLiver enzymesDrug protocolsNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudySpinal Cord Injury StudyStudy drug infusionEnzyme levelsLiver enzyme levelsEffect of methylprednisoloneSpinal cord traumaDays post infusionSeverity of injuryTotal bilirubin testsSteroid protocolCord traumaLiver functionSpinal cordDrug infusionPost infusionInjury studiesLarge dosesBilirubin testInjury
1993
Pharmacological treatment of acute spinal cord injury: current status and future projects.
Bracken M. Pharmacological treatment of acute spinal cord injury: current status and future projects. Journal Of Emergency Medicine 1993, 11 Suppl 1: 43-8. PMID: 8445202.Peer-Reviewed Original ResearchConceptsAcute spinal cord injurySpinal cord injuryCord injurySecond National Acute Spinal Cord Injury StudyNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudySpinal Cord Injury StudyEffectiveness of methylprednisoloneMethylprednisolone-treated patientsRecovery of motorHours of injuryLevel of injuryMethylprednisolone groupPinprick sensationTirilazad mesylateMethylprednisolone infusionGlucocorticoid activityInitial bolusNeurological functionPharmacological treatmentMotor functionSpinal cordInjury studiesSensory functionInjury
1992
The Second National Acute Spinal Cord Injury Study.
Young W, Bracken M. The Second National Acute Spinal Cord Injury Study. Journal Of Neurotrauma 1992, 9 Suppl 1: s397-405. PMID: 1588630.Peer-Reviewed Original ResearchConceptsSecond National Acute Spinal Cord Injury StudyNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudySpinal Cord Injury StudySpinal cord injuryNeurologic scoresCord injuryInjury studiesHuman spinal cord injurySpinal cord injury careSevere spinal cord injuryBeneficial effectsSignificant beneficial effectNeurologic recoverySuch patientsPatient populationInjury careLumbosacral segmentsFunctional assessmentLesion siteInjury severityPatientsSensory functionMultivariate analysisMethylprednisolonePharmacological treatment of acute spinal cord injury: current status and future prospects
Bracken M. Pharmacological treatment of acute spinal cord injury: current status and future prospects. Spinal Cord 1992, 30: 102-107. PMID: 1589282, DOI: 10.1038/sc.1992.34.Peer-Reviewed Original ResearchMethylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study.
Bracken M, Shepard M, Collins W, Holford T, Baskin D, Eisenberg H, Flamm E, Leo-Summers L, Maroon J, Marshall L, Perot P, Piepmeier J, Sonntag V, Wagner F, Wilberger J, Winn H, Young W. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. Journal Of Neurosurgery 1992, 76: 23-31. PMID: 1727165, DOI: 10.3171/jns.1992.76.1.0023.Peer-Reviewed Original ResearchConceptsHours of injuryAcute spinal cord injurySpinal cord injuryNaloxone treatmentCord injuryMotor functionSecond National Acute Spinal Cord Injury StudyNational Acute Spinal Cord Injury StudyAcute Spinal Cord Injury StudySpinal Cord Injury StudyAcute spinal cord traumaPreservation of motorTrial of methylprednisoloneSpinal cord traumaTotal sensoryPlacebo groupCord traumaNeurological functionStudy doseEmergency roomMethylprednisoloneInjury studiesMortality ratePatientsSensory function